Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
1.645
+0.035 (2.17%)
At close: Nov 13, 2026, 4:00 PM EST
1.688
+0.043 (2.63%)
After-hours: Nov 13, 2026, 7:56 PM EST
Altimmune Market Cap
Altimmune has a market cap or net worth of $320.1 million as of November 13, 2026. It is the 17,482nd most valuable company in the world and the 3,089th biggest in the United States. Its market cap has decreased by 27.42% in one year.
Market Cap
320.10M
Enterprise Value
91.24M
1-Year Change
-27.42%
Global Rank
Country Rank
#3,089 United States
Category
ChartMarket Cap Chart
Since October 6, 2005, Altimmune's market cap has increased from $81.50M to $320.10M, an increase of 292.76%. That is a compound annual growth rate of 6.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 320.10M | -14.96% |
| Dec 31, 2025 | 376.40M | -26.60% |
| Dec 31, 2024 | 512.80M | -15.16% |
| Dec 29, 2023 | 604.40M | -25.26% |
| Dec 30, 2022 | 808.70M | 122.17% |
| Dec 31, 2021 | 364.00M | -2.41% |
| Dec 31, 2020 | 373.00M | 1,186.21% |
| Dec 31, 2019 | 29.00M | 61.11% |
| Dec 31, 2018 | 18.00M | -42.12% |
| Dec 29, 2017 | 31.10M | -85.66% |
| Dec 30, 2016 | 216.90M | 77.06% |
| Dec 31, 2015 | 122.50M | 6.80% |
| Dec 31, 2014 | 114.70M | 17.88% |
| Dec 31, 2013 | 97.30M | 79.52% |
| Dec 31, 2012 | 54.20M | -11.58% |
| Dec 30, 2011 | 61.30M | -64.57% |
| Dec 31, 2010 | 173.00M | 210.59% |
| Dec 31, 2009 | 55.70M | -6.39% |
| Dec 31, 2008 | 59.50M | -31.77% |
| Dec 31, 2007 | 87.20M | 1.04% |
| Dec 29, 2006 | 86.30M | 4.10% |
| Dec 30, 2005 | 82.90M | 1.72% |
| Oct 6, 2005 | 81.50M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 405.23M |
| C4 Therapeutics | 393.95M |
| Prelude Therapeutics | 387.26M |
| Editas Medicine | 386.62M |
| Alector | 376.66M |
| Aspen Neuroscience | 372.50M |
| Fennec Pharmaceuticals | 371.01M |
| Precision BioSciences | 362.62M |